Prenetics Global(NASDAQ) PRENW

Market CapN/A

Since IPO (2021)-99%

5 Year-98%

1 Year-57%

1 Month-15%

$0.01

+34.91%

+0.00Today

Prenetics Global last closing stock price
Metric	Price	Date
Last close	USD 0.01	2026-08-31

Prenetics Global stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+30.86%	USD 0.01	2026-08-24
1 month	-15.3%	USD 0.01	2026-07-31
3 month	-33.75%	USD 0.02	2026-06-02
Year to date	-64.43%	USD 0.03	2025-12-31
1 year	-57.43%	USD 0.02	2025-08-26
3 year	-79.34%	USD 0.05	2023-09-01
5 year	-98.44%	USD 0.68	2021-09-01
Since inception	-98.88%	USD 0.95	2021-07-19

Prenetics Global Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$142.56M

Net Income (TTM)

-$67.61M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-0.08 (Low)

Dividend

$0.00

Beta (Volatility)

-0.08 (Low)

Price

$0.01

Volume

317

Open

$0.01

Price

$0.01

Volume

317

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.04

Estimated Earnings Date

Nov 5, 2026

Dividend

$0.00

Beta (Volatility)

-0.08 (Low)

Price

$0.01

Volume

317

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.04

Estimated Earnings Date

Nov 5, 2026

PRENW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Prenetics Global

Prenetics Global Limited is a leading investment holding company specializing in diagnostics and genetic testing. The company offers innovative health solutions, including consumer genetic testing and rapid detection health monitoring systems.

Products and Services

CircleDNA, a comprehensive consumer genetic testing solution
Circle HealthPod, a rapid COVID-19 detection system
ColoClear, a non-invasive colorectal cancer screening test

Growth Outlook

Revenue of $35.95 million in Q1 2026, showing strong market demand
Significant cash reserves of $56.02 million, supporting future growth initiatives
Expansion into new markets anticipated to drive revenue growth

Financial Highlights

Trailing twelve months (TTM) revenue of $136.5 million, indicating robust performance
Current ratio of 5.15, reflecting strong liquidity position
Net income of -$23.1 million in Q1 2026, highlighting ongoing investment in growth

Prenetics Global Limited operates in the healthcare sector, focusing on innovative diagnostic solutions. The company's diverse product portfolio positions it well to capitalize on the growing demand for genetic testing and health monitoring. Recent financial performance indicates a solid revenue stream, with a notable increase in Q1 2026. The strong liquidity position, as evidenced by a current ratio of 5.15, provides a buffer for future investments and operational needs. Despite reporting a net loss, the company continues to invest in growth opportunities, suggesting a commitment to long-term success in the evolving healthcare landscape.

AI Generated • Aug 5, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Headquarters

Hong Kong, HK

PRENW Financials

Key Financial Metrics (TTM)

Gross Margin

62.61%

Operating Margin

-35.20%

Net Income Margin

-47.43%

Return on Equity

-49.17%

Return on Capital

-21.57%

Return on Assets

-44.00%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

317

Avg. Volume

40.20K

Financials (TTM)

Gross Profit

$89.25M

Operating Income

-$50.18M

EBITDA

-$62.52M

Operating Cash Flow

-$49.39M

Capital Expenditure

$15.25M

Free Cash Flow

-$34.14M

Cash & ST Invst.

$109.39M

Total Debt

$682.00K

Prenetics Global Performance Analysis

Prenetics Global sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	33.2%
Q4	2025-12-31	55.2%
Q1	2026-03-31	-1.7%
Q2	2026-06-30	29.3%

Prenetics Global sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	43.6%
Q4	2025-12-31	-230.2%
Q1	2026-03-31	22.3%
Q2	2026-06-30	61.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$46.49M

+162.9%

Gross Profit

$30.20M

+314.4%

Gross Margin

64.97%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$8.98M

+27.6%

EBITDA

-$21.73M

-99.5%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$109.39M

+294.8%

Total Debt

$682.00K

-73.5%

Accounts Receivable

$5.13M

-48.8%

Inventory

$13.99M

+225.6%

Long Term Debt

$144.00K

-86.3%

Short Term Debt

$538.00K

-64.7%

Return on Assets

-44.00%

N/A

Return on Invested Capital

-42.85%

N/A

Free Cash Flow

$0.00

N/A

Operating Cash Flow

-$15.45M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NUWENuwellis, Inc.

NUWENuwellis, Inc.$0.76-4.45%

OCEAOcean Biomedical, Inc.

OCEAOcean Biomedical, Inc.$0.00-14.29%

BACKIMAC Holdings, Inc.

BACKIMAC Holdings, Inc.$0.00+0.00%

NLSPNLS Pharmaceutics AG

NLSPNLS Pharmaceutics AG$2.91-12.61%

BCTXWBriaCell Therapeutics Corp.

BCTXWBriaCell Therapeutics Corp.$0.00-0.00%

SABSSAB Biotherapeutics, Inc.

SABSSAB Biotherapeutics, Inc.$3.70-0.27%

SRZNSurrozen, Inc.

SRZNSurrozen, Inc.$22.20+0.82%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$14.06+0.06%

NVDANvidia

NVDANvidia$217.44-0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.33-0.06%

INTCIntel

INTCIntel$88.97-0.01%

ONDSOndas

ONDSOndas$7.04-0.08%

NUNu Holdings

NUNu Holdings$14.46-0.01%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.38-0.02%

Questions About PRENW

What is the current price of Prenetics Global?

Prenetics Global is trading at $0.01 per share.

What is the 52-week range for Prenetics Global?

Over the past 52 weeks, Prenetics Global has traded between $0.01 and $0.04.

How much debt does Prenetics Global have?

Prenetics Global total debt is unavailable.

How much cash does Prenetics Global have on hand?

Prenetics Global does not have cash on hand data available.

What is Prenetics Global’s dividend yield?

Prenetics Global does not currently have a dividend yield.

Prenetics Global(NASDAQ) PRENW

Prenetics Global Financials at a Glance

PRENW News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Prenetics Global

PRENW Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Prenetics Global Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PRENW

What is the current price of Prenetics Global?

What is the 52-week range for Prenetics Global?

How much debt does Prenetics Global have?

How much cash does Prenetics Global have on hand?

What is Prenetics Global’s dividend yield?

Premium Investing Services